SMTRX vs. NEFRX
SMTRX (ALPS/Smith Total Return Bond Fund) and NEFRX (Loomis Sayles Core Plus Bond Fund) are both Intermediate Core-Plus Bond funds. With a 1.00 correlation, they move nearly in lockstep. SMTRX charges 0.99%/yr vs 0.71%/yr for NEFRX.
Performance
SMTRX vs. NEFRX - Performance Comparison
Loading charts...
Returns By Period
SMTRX
- 1D
- -0.21%
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
NEFRX
- 1D
- -0.26%
- 1M
- 0.01%
- YTD
- 0.05%
- 6M
- 0.08%
- 1Y
- 4.46%
- 3Y*
- 3.53%
- 5Y*
- -0.07%
- 10Y*
- 2.15%
SMTRX vs. NEFRX - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
SMTRX ALPS/Smith Total Return Bond Fund | -0.10% |
NEFRX Loomis Sayles Core Plus Bond Fund | -0.17% |
Correlation
The correlation between SMTRX and NEFRX is 1.00 - these two move nearly in lockstep. At this level, holding both provides almost no diversification benefit. If you already own one, adding the other does little to reduce portfolio risk.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since May 29, 2026 | 1.00 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SMTRX vs. NEFRX — Risk / Return Rank
SMTRX
NEFRX
SMTRX vs. NEFRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ALPS/Smith Total Return Bond Fund (SMTRX) and Loomis Sayles Core Plus Bond Fund (NEFRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| SMTRX | NEFRX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 1.47 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.01 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.44 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -2.96 | 0.73 | -3.69 |
Drawdowns
SMTRX vs. NEFRX - Drawdown Comparison
The maximum SMTRX drawdown since its inception was -0.21%, smaller than the maximum NEFRX drawdown of -25.45%. Use the drawdown chart below to compare losses from any high point for SMTRX and NEFRX.
Loading charts...
Drawdown Indicators
| SMTRX | NEFRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -0.21% | -25.45% | +25.24% |
Max Drawdown (1Y)Largest decline over 1 year | — | -2.92% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -7.95% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -18.55% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -18.76% | — |
Current DrawdownCurrent decline from peak | -0.21% | -2.15% | +1.94% |
Average DrawdownAverage peak-to-trough decline | -0.08% | -3.97% | +3.89% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 1.18% | — |
Volatility
SMTRX vs. NEFRX - Volatility Comparison
Loading charts...
Volatility by Period
| SMTRX | NEFRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 1.36% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 2.74% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 2.47% | 4.20% | -1.73% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 2.47% | 6.23% | -3.76% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 2.47% | 5.03% | -2.56% |
SMTRX vs. NEFRX - Expense Ratio Comparison
SMTRX has a 0.99% expense ratio, which is higher than NEFRX's 0.71% expense ratio.
Dividends
SMTRX vs. NEFRX - Dividend Comparison
SMTRX's dividend yield for the trailing twelve months is around 0.36%, less than NEFRX's 3.62% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NEFRX Loomis Sayles Core Plus Bond Fund | 3.62% | 3.97% | 3.90% | 3.58% | 3.10% | 2.34% | 4.04% | 2.51% | 2.87% | 2.68% | 3.17% | 2.58% |
SMTRX ALPS/Smith Total Return Bond Fund | 0.36% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
With a correlation of 1.00, SMTRX and NEFRX move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.
Find the right allocation for SMTRX and NEFRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer